Aspire Biopharma logo
Aspire Biopharma
ASBP | NASDAQ
Chart Builder DCF Calculator
$8.06
-$0.35 (-4.16%)
At close: Nov 16, 2026, 4:00 PM ET
$8.30
+$0.24 (+2.98%)
After-hours: Nov 16, 2026, 7:30 PM ET

Aspire Biopharma Balance Sheet

Balance sheet explained
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
1M 3.63K – 497.26K –
– – – – –
– 6.67M 19.9M 299K –
– – – 298.79M 293.22K
– 36.5K – – –
253.16K – – – –
55.1K 107.85K 81.22K 600.49K 293.22K
1.31M 147.99K 81.22K 1.1M 293.22K
– – – – –
– – – – –
– 6.67M 19.9M 299.08M 293.22K
1.31M 147.99K 19.98M 300.18M 293.22K
1.01M 310.22K – 180.63K 273
– – – 80.17 –
1.38M 1.27M 12.38K 27.97K 238.6K
4.84M 111.03K 390.94K -28.05K –
7.59M 1.69M 403.33K 303.32K 293.7K
– – – – –
95.66K – – 10.81M –
95.66K – – 10.81M –
7.69M 1.69M 403.33K 11.12M 293.7K
1.38M 1.27M 12.38K 27.97K 238.6K
-6.38M -1.54M 19.58M 289.07M -475
-4.27 -40.17 40.83 321.74 0
353 69 19.9M 299M 718
-27.26M -2.78M -11.29M -9.94M -25.48K
– – – – –
-6.38M -1.54M 19.58M 289.07M -475
– 6.67M 19.9M 299K –

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.